ARID1A alterations function as a biomarker for longer progression-free survival after anti-PD-1/PD-L1 immunotherapy
====================================================================================================================

* Ryosuke Okamura
* Shumei Kato
* Suzanna Lee
* Rebecca E Jimenez
* Jason K Sicklick
* Razelle Kurzrock